class name | count |
---|
class name | count |
---|---|
Aspergillaceae | 4 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00003008
![]() |
Ochratoxin A
|
CHEMBL589366
CHEMBL592694 CHEMBL603156 CHEMBL600271 |
C025589
|
20 / 32 / 57 | 234 / 18 |
![]() |
C00037570
![]() |
Ochratoxin B
|
C045354
|
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003008 | 7 / 37 |
P04062 | Glucosylceramidase | Enzyme | C00003008 | 6 / 4 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00003008 | 1 / 1 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00003008 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00003008 | 3 / 1 |
P11473 | Vitamin D3 receptor | NR1I1 | C00003008 | 2 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00003008 | 0 / 0 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00003008 | 0 / 0 |
Q4U2R8 | Solute carrier family 22 member 6 | Antiporter | C00003008 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00003008 | 0 / 1 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00003008 | 5 / 3 |
P06280 | Alpha-galactosidase A | Enzyme | C00003008 | 1 / 1 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003008 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00003008 | 1 / 1 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00003008 | 2 / 2 |
P03372 | Estrogen receptor | NR3A1 | C00003008 | 1 / 1 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00003008 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00003008 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00003008 | 3 / 4 |
Q9NSA0 | Solute carrier family 22 member 11 | Transporter | C00003008 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
10351 | ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 |
C00003008
|
10058 | ABCB6, ABC, ABC14, DUH3, LAN, MCOPCB7, MTABC3, PRP, umat | ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
C00003008
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00003008
|
30 | ACAA1, ACAA, PTHIO, THIO | acetyl-CoA acyltransferase 1 (EC:2.3.1.16) |
C00003008
|
100380740 |
C00003008
|
||
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00003008
|
204 | AK2, ADK2, AK_2 | adenylate kinase 2 (EC:2.7.4.3) |
C00003008
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00003008
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00003008
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00003008
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00003008
|
79868 | ALG13, CDG1S, CXorf45, GLT28D1, MDS031, TDRD13, YGL047W | ALG13, UDP-N-acetylglucosaminyltransferase subunit (EC:3.4.19.12 2.4.1.141) |
C00003008
|
8639 | AOC3, HPAO, SSAO, VAP-1, VAP1 | amine oxidase, copper containing 3 (EC:1.4.3.21) |
C00003008
|
317 | APAF1, APAF-1, CED4 | apoptotic peptidase activating factor 1 |
C00003008
|
8542 | APOL1, APO-L, APOL, APOL-I, FSGS4 | apolipoprotein L, 1 |
C00003008
|
10565 | ARFGEF1, ARFGEP1, BIG1, P200 | ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited) |
C00003008
|
10123 | ARL4C, ARL7, LAK | ADP-ribosylation factor-like 4C |
C00003008
|
26225 | ARL5A, ARFLP5, ARL5 | ADP-ribosylation factor-like 5A |
C00003008
|
488 | ATP2A2, ATP2B, DAR, DD, SERCA2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (EC:3.6.3.8) |
C00003008
|
506 | ATP5B, ATPMB, ATPSB | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (EC:3.6.3.14) |
C00003008
|
513 | ATP5D | ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit (EC:3.6.1.14) |
C00003008
|
522 | ATP5J, ATP5, ATP5A, ATPM, CF6, F6 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 (EC:3.6.1.14) |
C00003008
|
10677 | AVIL, ADVIL, DOC6, p92 | advillin |
C00003008
|
10678 | B3GNT2, B3GN-T2, B3GNT, B3GNT-2, B3GNT1, BETA3GNT, BGNT2, BGnT-2 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (EC:2.4.1.149) |
C00003008
|
11285 | B4GALT7, EDSP1, XGALT1, XGPT1 | xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (EC:2.4.1.133) |
C00003008
|
397543 |
C00003008
|
||
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00003008
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00003008
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00003008
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00003008
|
10904 | BLCAP, BC10 | bladder cancer associated protein |
C00003008
|
716061 |
C00003008
|
||
735 | C9 | complement component 9 |
C00003008
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00003008
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00003008
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00003008
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00003008
|
847 | CAT | catalase (EC:1.11.1.6) |
C00003008
|
6358 | CCL14, CC-1, CC-3, CKB1, HCC-1, HCC-1(1-74), HCC-1/HCC-3, HCC-3, MCIF, NCC-2, NCC2, SCYA14, SCYL2, SY14 | chemokine (C-C motif) ligand 14 |
C00003008
|
891 | CCNB1, CCNB | cyclin B1 |
C00003008
|
900 | CCNG1, CCNG | cyclin G1 |
C00003008
|
100133941 | CD24, CD24A | CD24 molecule |
C00003008
|
10421 | CD2BP2, FWP010, LIN1, PPP1R59, Snu40, U5-52K | CD2 (cytoplasmic tail) binding protein 2 |
C00003008
|
995 | CDC25C, CDC25, PPP1R60 | cell division cycle 25C (EC:3.1.3.48) |
C00003008
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00003008
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003008
|
1050 | CEBPA, C/EBP-alpha, CEBP | CCAAT/enhancer binding protein (C/EBP), alpha |
C00003008
|
1051 | CEBPB, C/EBP-beta, CRP2, IL6DBP, LAP, LIP, NF-IL6, TCF5 | CCAAT/enhancer binding protein (C/EBP), beta |
C00003008
|
1153 | CIRBP, CIRP | cold inducible RNA binding protein |
C00003008
|
51397 | COMMD10, PTD002 | COMM domain containing 10 |
C00003008
|
51122 | COMMD2 | COMM domain containing 2 |
C00003008
|
10229 | COQ7, CAT5, CLK-1, CLK1 | coenzyme Q7 homolog, ubiquinone (yeast) |
C00003008
|
1329 | COX5B, COXVB | cytochrome c oxidase subunit Vb (EC:1.9.3.1) |
C00003008
|
9167 | COX7A2L, COX7AR, COX7RP, EB1, SIG81 | cytochrome c oxidase subunit VIIa polypeptide 2 like |
C00003008
|
1351 | COX8A, COX, COX8, COX8-2, COX8L, VIII, VIII-L | cytochrome c oxidase subunit VIIIA (ubiquitous) (EC:1.9.3.1) |
C00003008
|
57325 | CSRP2BP, ATAC2, CRP2BP, KAT14, PRO1194, dJ717M23.1 | CSRP2 binding protein |
C00003008
|
1495 | CTNNA1, CAP102 | catenin (cadherin-associated protein), alpha 1, 102kDa |
C00003008
|
9820 | CUL7, KIAA0076, dJ20C7.5 | cullin 7 |
C00003008
|
1727 | CYB5R3, B5R, DIA1 | cytochrome b5 reductase 3 (EC:1.6.2.2) |
C00003008
|
1535 | CYBA, p22-PHOX | cytochrome b-245, alpha polypeptide |
C00003008
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00003008
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00003008
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00003008
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00003008
|
1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00003008
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00003008
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00003008
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00003008
|
1577 | CYP3A5, CP35, CYPIIIA5, P450PCN3, PCN3 | cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1) |
C00003008
|
84259 | DCUN1D5 | DCN1, defective in cullin neddylation 1, domain containing 5 |
C00003008
|
1717 | DHCR7, SLOS | 7-dehydrocholesterol reductase (EC:1.3.1.21) |
C00003008
|
56616 | DIABLO, DFNA64, SMAC | diablo, IAP-binding mitochondrial protein |
C00003008
|
11083 | DIDO1, BYE1, C20orf158, DATF-1, DATF1, DIDO2, DIDO3, DIO-1, DIO1, dJ885L7.8 | death inducer-obliterator 1 |
C00003008
|
129563 | DIS3L2, FAM6A, PRLMNS, hDIS3L2 | DIS3 mitotic control homolog (S. cerevisiae)-like 2 |
C00003008
|
8847 | DLEU2, 1B4, BCMSUN, DLB2, LEU2, LINC00022, MIR15AHG, NCRNA00022, RFP2OS, TRIM13OS | deleted in lymphocytic leukemia 2 (non-protein coding) |
C00003008
|
1798 | DPAGT1, ALG7, CDG-Ij, CDG1J, CMSTA2, D11S366, DGPT, DPAGT, DPAGT2, G1PT, GPT, UAGT, UGAT | dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) (EC:2.7.8.15) |
C00003008
|
23333 | DPY19L1 | dpy-19-like 1 (C. elegans) |
C00003008
|
1632 | ECI1, DCI | enoyl-CoA delta isomerase 1 (EC:5.3.3.8) |
C00003008
|
30844 | EHD4, PAST4 | EH-domain containing 4 |
C00003008
|
27436 | EML4, C2orf2, ELP120, EMAP-4, EMAPL4, ROPP120 | echinoderm microtubule associated protein like 4 |
C00003008
|
2029 | ENSA, ARPP-19e | endosulfine alpha |
C00003008
|
2034 | EPAS1, ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73 | endothelial PAS domain protein 1 |
C00003008
|
2066 | ERBB4, ALS19, HER4, p180erbB4 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 (EC:2.7.10.1) |
C00003008
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00003008
|
2153 | F5, FVL, PCCF, RPRGL1, THPH2 | coagulation factor V (proaccelerin, labile factor) |
C00003008
|
2167 | FABP4, A-FABP, AFABP, ALBP, aP2 | fatty acid binding protein 4, adipocyte |
C00003008
|
8772 | FADD, MORT1 | Fas (TNFRSF6)-associated via death domain |
C00003008
|
3992 | FADS1, D5D, FADS6, FADSD5, LLCDL1, TU12 | fatty acid desaturase 1 (EC:1.14.19.-) |
C00003008
|
81889 | FAHD1, C16orf36, YISKL | fumarylacetoacetate hydrolase domain containing 1 (EC:3.7.1.5) |
C00003008
|
151354 | FAM84A, NSE1, PP11517 | family with sequence similarity 84, member A |
C00003008
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00003008
|
8817 | FGF18, FGF-18, ZFGF5 | fibroblast growth factor 18 |
C00003008
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00003008
|
2487 | FRZB, FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, OS1, SFRP3, SRFP3, hFIZ | frizzled-related protein |
C00003008
|
2528 | FUT6, FCT3A, FT1A, Fuc-TVI, FucT-VI | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) (EC:2.4.1.65) |
C00003008
|
35646 |
C00003008
|
||
2697 | GJA1, AVSD3, CMDR, CX43, DFNB38, GJAL, HLHS1, HSS, ODDD | gap junction protein, alpha 1, 43kDa |
C00003008
|
2814 | GP5, CD42d, GPV | glycoprotein V (platelet) |
C00003008
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00003008
|
2878 | GPX3, GPx-P, GSHPx-3, GSHPx-P | glutathione peroxidase 3 (plasma) (EC:1.11.1.9) |
C00003008
|
9446 | GSTO1, GSTO_1-1, GSTTLp28, P28, SPG-R | glutathione S-transferase omega 1 (EC:2.5.1.18 1.8.5.1 1.20.4.2) |
C00003008
|
404672 | GTF2H5, C6orf175, TFB5, TFIIH, TGF2H5, TTD, TTD-A, TTDA, bA120J8.2 | general transcription factor IIH, polypeptide 5 |
C00003008
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00003008
|
10767 | HBS1L, EF-1a, ERFS, HBS1, HSPC276 | HBS1-like (S. cerevisiae) |
C00003008
|
3010 | HIST1H1T, H1FT, H1t, dJ221C16.2 | histone cluster 1, H1t |
C00003008
|
3148 | HMGB2, HMG2 | high mobility group box 2 |
C00003008
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00003008
|
3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A |
C00003008
|
3309 | HSPA5, BIP, GRP78, MIF2 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
C00003008
|
3313 | HSPA9, CSA, GRP-75, GRP75, HSPA9B, MOT, MOT2, MTHSP75, PBP74 | heat shock 70kDa protein 9 (mortalin) |
C00003008
|
3315 | HSPB1, CMT2F, HMN2B, HS.76067, HSP27, HSP28, Hsp25, SRP27 | heat shock 27kDa protein 1 |
C00003008
|
3420 | IDH3B, H-IDHB, RP46 | isocitrate dehydrogenase 3 (NAD+) beta (EC:1.1.1.41) |
C00003008
|
3421 | IDH3G, H-IDHG | isocitrate dehydrogenase 3 (NAD+) gamma (EC:1.1.1.41) |
C00003008
|
3481 | IGF2, C11orf43, IGF-II, PP9974 | insulin-like growth factor 2 (somatomedin A) |
C00003008
|
3484 | IGFBP1, AFBP, IBP1, IGF-BP25, PP12, hIGFBP-1 | insulin-like growth factor binding protein 1 |
C00003008
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00003008
|
7850 | IL1R2, CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c, IL1RB | interleukin 1 receptor, type II |
C00003008
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00003008
|
23210 | JMJD6, PSR, PTDSR, PTDSR1 | jumonji domain containing 6 (EC:1.14.11.-) |
C00003008
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00003008
|
3726 | JUNB, AP-1 | jun B proto-oncogene |
C00003008
|
23189 | KANK1, ANKRD15, CPSQ2, KANK | KN motif and ankyrin repeat domains 1 |
C00003008
|
3758 | KCNJ1, KIR1.1, ROMK, ROMK1 | potassium inwardly-rectifying channel, subfamily J, member 1 |
C00003008
|
3772 | KCNJ15, IRKK, KIR1.3, KIR4.2 | potassium inwardly-rectifying channel, subfamily J, member 15 |
C00003008
|
23588 | KLHDC2, HCLP-1, HCLP1, LCP | kelch domain containing 2 |
C00003008
|
3866 | KRT15, CK15, K15, K1CO | keratin 15 |
C00003008
|
4023 | LPL, HDLCQ11, LIPD | lipoprotein lipase (EC:3.1.1.34) |
C00003008
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00003008
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00003008
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00003008
|
22919 | MAPRE1, EB1 | microtubule-associated protein, RP/EB family, member 1 |
C00003008
|
4155 | MBP | myelin basic protein |
C00003008
|
9412 | MED21, SRB7, SURB7, hSrb7 | mediator complex subunit 21 |
C00003008
|
9526 | MPDU1, CDGIF, HBEBP2BPA, Lec35, My008, PP3958, PQLC5, SL15 | mannose-P-dolichol utilization defect 1 |
C00003008
|
23164 | MPRIP, M-RIP, MRIP, RHOIP3, RIP3, p116Rip | myosin phosphatase Rho interacting protein |
C00003008
|
4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00003008
|
4490 | MT1B, MT1, MT1Q, MTP | metallothionein 1B |
C00003008
|
4502 | MT2A, MT2 | metallothionein 2A |
C00003008
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00003008
|
79829 | NAA40, NAT11, PATT1 | N(alpha)-acetyltransferase 40, NatD catalytic subunit (EC:2.3.1.-) |
C00003008
|
4668 | NAGA, D22S674, GALB | N-acetylgalactosaminidase, alpha- (EC:3.2.1.49) |
C00003008
|
55577 | NAGK, GNK, HSA242910 | N-acetylglucosamine kinase (EC:2.7.1.59) |
C00003008
|
4694 | NDUFA1, CI-MWFE, MWFE, ZNF183 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa (EC:1.6.99.3) |
C00003008
|
4705 | NDUFA10, CI-42KD, CI-42k | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa (EC:1.6.5.3 1.6.99.3) |
C00003008
|
4696 | NDUFA3, B9, CI-B9 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa |
C00003008
|
4701 | NDUFA7, B14.5a | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa |
C00003008
|
4708 | NDUFB2, AGGG, CI-AGGG | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa (EC:1.6.5.3 1.6.99.3) |
C00003008
|
4713 | NDUFB7, B18, CI-B18 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa (EC:1.6.5.3 1.6.99.3) |
C00003008
|
4717 | NDUFC1, KFYI | NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
C00003008
|
4726 | NDUFS6, CI-13kA, CI-13kD-A, CI13KDA | NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) |
C00003008
|
374291 | NDUFS7, CI-20, CI-20KD, MY017, PSST | NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) |
C00003008
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00003008
|
3084 | NRG1, ARIA, GGF, GGF2, HGL, HRG, HRG1, HRGA, MST131, NDF, SMDF | neuregulin 1 |
C00003008
|
29095 | ORMDL2, MST095, MSTP095, adoplin-2 | ORM1-like 2 (S. cerevisiae) |
C00003008
|
10914 | PAPOLA, PAP | poly(A) polymerase alpha (EC:2.7.7.19) |
C00003008
|
5106 | PCK2, PEPCK, PEPCK-M, PEPCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) (EC:4.1.1.32) |
C00003008
|
5111 | PCNA | proliferating cell nuclear antigen |
C00003008
|
5165 | PDK3, CMTX6 | pyruvate dehydrogenase kinase, isozyme 3 (EC:2.7.11.2) |
C00003008
|
55825 | PECR, DCRRP, HPDHASE, HSA250303, PVIARL, SDR29C1, TERP | peroxisomal trans-2-enoyl-CoA reductase (EC:1.3.1.38) |
C00003008
|
5211 | PFKL, PFK-B | phosphofructokinase, liver (EC:2.7.1.11) |
C00003008
|
5230 | PGK1, MIG10, PGKA | phosphoglycerate kinase 1 (EC:2.7.2.3) |
C00003008
|
55650 | PIGV, GPI-MT-II, HPMRS1, PIG-V | phosphatidylinositol glycan anchor biosynthesis, class V |
C00003008
|
80235 | PIGZ, GPI-MT-IV, PIG-Z, SMP3 | phosphatidylinositol glycan anchor biosynthesis, class Z |
C00003008
|
5329 | PLAUR, CD87, U-PAR, UPAR, URKR | plasminogen activator, urokinase receptor |
C00003008
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00003008
|
5519 | PPP2R1B, PP2A-Abeta, PR65B | protein phosphatase 2, regulatory subunit A, beta (EC:3.1.3.16) |
C00003008
|
5532 | PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta | protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16) |
C00003008
|
10113 | PREB, SEC12 | prolactin regulatory element binding |
C00003008
|
5553 | PRG2, BMPG, MBP, MBP1 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) |
C00003008
|
5629 | PROX1 | prospero homeobox 1 |
C00003008
|
8899 | PRPF4B, PR4H, PRP4, PRP4H, PRP4K, dJ1013A10.1 | pre-mRNA processing factor 4B (EC:2.7.11.1) |
C00003008
|
5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00003008
|
5912 | RAP2B | RAP2B, member of RAS oncogene family |
C00003008
|
10125 | RASGRP1, CALDAG-GEFI, CALDAG-GEFII, RASGRP, V, hRasGRP1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
C00003008
|
5928 | RBBP4, NURF55, RBAP48 | retinoblastoma binding protein 4 |
C00003008
|
5984 | RFC4, A1, RFC37 | replication factor C (activator 1) 4, 37kDa |
C00003008
|
388 | RHOB, ARH6, ARHB, MST081, MSTP081, RHOH6 | ras homolog family member B |
C00003008
|
6117 | RPA1, HSSB, MST075, REPA1, RF-A, RP-A, RPA70 | replication protein A1, 70kDa |
C00003008
|
6137 | RPL13, BBC1, D16S444E, D16S44E, L13 | ribosomal protein L13 (EC:3.6.5.3) |
C00003008
|
10556 | RPP30, TSG15 | ribonuclease P/MRP 30kDa subunit (EC:3.1.26.5) |
C00003008
|
6209 | RPS15, RIG, S15 | ribosomal protein S15 |
C00003008
|
80230 | RUFY1, RABIP4, ZFYVE12 | RUN and FYVE domain containing 1 |
C00003008
|
6305 | SBF1, CMT4B3, DENND7A, MTMR5 | SET binding factor 1 |
C00003008
|
6309 | SC5D, ERG3, S5DES, SC5DL | sterol-C5-desaturase (EC:1.14.21.6) |
C00003008
|
22828 | SCAF8, RBM16 | SR-related CTD-associated factor 8 |
C00003008
|
6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) |
C00003008
|
5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00003008
|
6464 | SHC1, SHC, SHCA | SHC (Src homology 2 domain containing) transforming protein 1 |
C00003008
|
4891 | SLC11A2, DCT1, DMT1, NRAMP2 | solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
C00003008
|
55867 | SLC22A11, OAT4, hOAT4 | solute carrier family 22 (organic anion/urate transporter), member 11 |
C00003008
|
9356 | SLC22A6, HOAT1, OAT1, PAHT, ROAT1 | solute carrier family 22 (organic anion transporter), member 6 |
C00003008
|
9376 | SLC22A8, OAT3 | solute carrier family 22 (organic anion transporter), member 8 |
C00003008
|
7779 | SLC30A1, ZNT1, ZRC1 | solute carrier family 30 (zinc transporter), member 1 |
C00003008
|
64924 | SLC30A5, ZNT5, ZNTL1, ZTL1, ZnT-5 | solute carrier family 30 (zinc transporter), member 5 |
C00003008
|
55676 | SLC30A6, MST103, MSTP103, ZNT6 | solute carrier family 30 (zinc transporter), member 6 |
C00003008
|
148867 | SLC30A7, ZNT7, ZnT-7, ZnTL2 | solute carrier family 30 (zinc transporter), member 7 |
C00003008
|
27173 | SLC39A1, ZIP1, ZIRTL | solute carrier family 39 (zinc transporter), member 1 |
C00003008
|
57181 | SLC39A10, LZT-Hs2 | solute carrier family 39 (zinc transporter), member 10 |
C00003008
|
23516 | SLC39A14, LZT-Hs4, NET34, ZIP14, cig19 | solute carrier family 39 (zinc transporter), member 14 |
C00003008
|
7922 | SLC39A7, D6S115E, D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7 | solute carrier family 39 (zinc transporter), member 7 |
C00003008
|
55334 | SLC39A9, ZIP-9, ZIP9 | solute carrier family 39, member 9 |
C00003008
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00003008
|
6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00003008
|
6652 | SORD, SORD1 | sorbitol dehydrogenase (EC:1.1.1.14) |
C00003008
|
6655 | SOS2 | son of sevenless homolog 2 (Drosophila) |
C00003008
|
55812 | SPATA7, HSD-3.1, HSD3, LCA3 | spermatogenesis associated 7 |
C00003008
|
26010 | SPATS2L, DNAPTP6, SGNP | spermatogenesis associated, serine-rich 2-like |
C00003008
|
6711 | SPTBN1, ELF, SPTB2, betaSpII | spectrin, beta, non-erythrocytic 1 |
C00003008
|
10254 | STAM2, Hbp, STAM2A, STAM2B | signal transducing adaptor molecule (SH3 domain and ITAM motif) 2 |
C00003008
|
6781 | STC1, STC | stanniocalcin 1 |
C00003008
|
8417 | STX7 | syntaxin 7 |
C00003008
|
23435 | TARDBP, ALS10, TDP-43 | TAR DNA binding protein |
C00003008
|
140738 | TMEM37, PR, PR1 | transmembrane protein 37 |
C00003008
|
757 | TMEM50B, C21orf4, HCVP7TP3 | transmembrane protein 50B |
C00003008
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00003008
|
7132 | TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60 | tumor necrosis factor receptor superfamily, member 1A |
C00003008
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00003008
|
7170 | TPM3, CAPM1, CFTD, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TM5, TPMsk3, TRK, hscp30 | tropomyosin 3 |
C00003008
|
22906 | TRAK1, MILT1, OIP106 | trafficking protein, kinesin binding 1 |
C00003008
|
8805 | TRIM24, PTC6, RNF82, TF1A, TIF1, TIF1A, TIF1ALPHA, hTIF1 | tripartite motif containing 24 |
C00003008
|
8295 | TRRAP, PAF350/400, PAF400, STAF40, TR-AP, Tra1 | transformation/transcription domain-associated protein |
C00003008
|
81027 | TUBB1 | tubulin, beta 1 class VI |
C00003008
|
25828 | TXN2, MT-TRX, MTRX, TRX2 | thioredoxin 2 |
C00003008
|
7351 | UCP2, BMIQ4, SLC25A8, UCPH | uncoupling protein 2 (mitochondrial, proton carrier) |
C00003008
|
7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00003008
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00003008
|
65109 | UPF3B, HUPF3B, MRXS14, RENT3B, UPF3X | UPF3 regulator of nonsense transcripts homolog B (yeast) |
C00003008
|
708396 |
C00003008
|
||
7388 | UQCRH, QCR6, UQCR8 | ubiquinol-cytochrome c reductase hinge protein (EC:1.10.2.2) |
C00003008
|
27089 | UQCRQ, MC3DN4, QCR8, QP-C, QPC, UQCR7 | ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa (EC:1.10.2.2) |
C00003008
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00003008
|
55339 | WDR33, NET14, WDC146 | WD repeat domain 33 |
C00003008
|
7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00003008
|
22834 | ZNF652 | zinc finger protein 652 |
C00003008
|
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
%606641 | Body mass index; bmi |
P37231
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#232300 | Glycogen storage disease ii |
P10253
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#211980 | Lung cancer |
P04637
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#601665 | Obesity |
P37231
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00125 | Fabry disease |
P06280
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D000236 | Adenoma |
C00003008
|
D001943 | Breast Neoplasms |
C00003008
|
D002277 | Carcinoma |
C00003008
|
D019465 | Craniofacial Abnormalities |
C00003008
|
D005355 | Fibrosis |
C00003008
|
D042822 | Genomic Instability |
C00003008
|
D007674 | Kidney Diseases |
C00003008
|
D007680 | Kidney Neoplasms |
C00003008
|
D008103 | Liver Cirrhosis |
C00003008
|
D008113 | Liver Neoplasms |
C00003008
|
D008325 | Mammary Neoplasms, Experimental |
C00003008
|
D008850 | Microphthalmos |
C00003008
|
D009436 | Neural Tube Defects |
C00003008
|
D011041 | Poisoning |
C00003008
|
D011201 | Poultry Diseases |
C00003008
|
D011230 | Precancerous Conditions |
C00003008
|
D013736 | Testicular Neoplasms |
C00003008
|
D014571 | Urologic Neoplasms |
C00003008
|